| Name | Title | Contact Details |
|---|---|---|
Dee Olomajeye |
Head of People and Senior Director of People Operations | Profile |
Deborah Knobelman |
Chief Financial Officer | Profile |
Tim Lu |
Chief Executive Officer and Co Founder | Profile |
Imago BioSciences is translating true scientific insights into transformative treatments allowing patients to live longer, disease-free lives.
Tranquis Therapeutics is discovering and developing innovative medicines with the potential to revolutionize the management of neurodegenerative and aging-related diseases and to dramatically reduce the burden these illnesses place on patients, families and societies worldwide.
Mavupharma is developing non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.
Isis Pharmaceuticals Inc is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. Icosavax is located in Seattle.